Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 and up

Mechanochemical ablation versus ultrasound-guided polidocanol foam sclerotherapy for great saphenous vein varicose veins

Official title: Mechanochemical Ablation Versus Ultrasound-Guided Foam Sclerotherapy of the Great Saphenous Vein: Randomized Clinical Trial

Run by University of Sao Paulo · NCT07561320 · Data updated 2026-11-12

This compares mechanochemical ablation and ultrasound-guided polidocanol foam sclerotherapy to see which better closes the great saphenous vein and improves symptoms in adults with symptomatic varicose veins.

More Varicose Veins of Lower Limb trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment50 (estimated)
SponsorUniversity of Sao Paulo
Academic / other
Locations1 site (São Paulo, São Paulo)
StatusRecruiting
StartedMay 2026
Main results expectedAugust 2027
Study endsNovember 2027
Registry record updatedMay 1, 2026
Trial IDNCT07561320 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with symptomatic varicose veins classified CEAP C2–C4 and ultrasound-confirmed great saphenous vein insufficiency measuring 6–12 mm at mid-thigh, who are eligible for minimally invasive endovenous treatment, are ideal candidates.

Probably not a fit

People with active deep vein thrombosis, recent pulmonary embolism or stroke, allergy to sclerosing agents, pregnancy, occlusive peripheral arterial disease, or GSV outside the 6–12 mm range are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Fifty patients with symptomatic varicose veins (CEAP C2–C4) and an insufficient great saphenous vein 6–12 mm in diameter will be randomized to either mechanochemical ablation using the Flebogrif® catheter or ultrasound-guided polidocanol foam sclerotherapy. Procedures are performed under ultrasound guidance and patients are followed with clinical exams and Doppler ultrasonography to document vein occlusion over the follow-up period. Primary endpoints are GSV occlusion rate on duplex ultrasound and disease-specific quality of life; secondary endpoints include procedure pain and treatment-related complications. This single-center, randomized Phase 4 comparison is conducted at Hospital das Clínicas da FMUSP in São Paulo.

Why it matters

Potential benefit: If successful, the approach could reduce vein recanalization and the need for repeat treatments while improving patients' leg symptoms and quality of life.

How similar studies have gone: Ultrasound-guided foam sclerotherapy is widely used but has higher recanalization rates in larger veins, while mechanochemical ablation has shown lower recanalization in several prior studies though results are not uniformly definitive.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* CEAP Classification C2, 3 or 4
* Insufficient great saphenous vein measuring 6-12 mm in the mid-thigh on Doppler ultrasound.

Exclusion Criteria:

* Allergy to sclerosing substances
* Deep venous thrombosis, stroke, or pulmonary embolism
* Local or generalized infection at the sclerotherapy site
* Prolonged immobilization
* Asymptomatic patent foramen ovale
* Pregnancy Occlusive peripheral arterial disease

Where it's running

  • Hospital da Clínicas da FMUSP
    São Paulo, São Paulo, Brazil
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • SEPS vs Open Ligation for Varicose Veins in the Leg

    This study tests whether subfascial endoscopic perforator surgery (SEPS) works better than open perforator ligation for adults with varicose veins in the leg.

    Recruiting King Edward Medical University · Lahore, Punjab Province · NCT07872150

  • Are hemorrhoids linked to varicose veins in the legs?

    This project will see if adults with hemorrhoids are more likely to have varicose veins in their lower limbs by comparing 200 people with hemorrhoids to 200 patients with other benign anorectal conditions.

    Recruiting Aydin Adnan Menderes University · Aydin, Efeler · NCT07317492

  • Comparing radiofrequency and microwave treatments for small varicose veins

    This study is testing whether ultrasound-guided radiofrequency or microwave treatments work better for people with small varicose veins.

    Recruiting Chengdu University of Traditional Chinese Medicine · Chengdu · NCT06711120

  • Observing pain during microwave treatment for varicose veins

    This study looks at how much pain patients feel during microwave treatment for varicose veins to see if different factors like age and weight affect their experience, with the goal of making the procedure more comfortable.

    Recruiting Chengdu University of Traditional Chinese Medicine · Chengdu, Sichuan · NCT06693245

  • Examining venous outflow in patients with pelvic varicosities

    This study is trying to see how blood flows in the legs of people with pelvic varicose veins to understand their symptoms better and find out if compression therapy helps.

    Recruiting Pirogov Russian National Research Medical University · Moskva · NCT06124664

  • Registry for chronic venous disease incidence and natural course

    This study is tracking the health and progress of people with varicose veins to see how the condition affects them over time.

    Recruiting Russian Phlebological Association · Saint Petersburg, Sankt-Peterburg · NCT04487314

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.